Početna › Demencija › New Jersey
Kliničke studije za Demencija u državi New Jersey
8 studija za Demencija traži sudionike na lokacijama u državi New Jersey.
Gradovi u državi New Jersey
Službeni tekst studije (engleski)
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, West Long Branch
U tijeku regrutacijaFaza 2
Od 55 do 90 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT06887192Comparison of Two Group Wellness Interventions for Individuals With Neurologic Conditions and Their Support Persons
- Kessler Foundation, East Hanover
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT05048966A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- The Cognitive and Research Center of New Jersey, Springfield
- Advanced Clinical Institute, West Long Branch
U tijeku regrutacijaFaza 3
Od 60 do 85 godina · Oba spola · Ažurirano 17. ruj 2026. · NCT06976203A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- CenExel AMRI, Toms River
U tijeku regrutacijaFaza 1
Od 50 do 85 godina · Oba spola · Ažurirano 24. kol 2026. · NCT06297590A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Advanced Memory Research Institute of New Jersey, Toms River
U tijeku regrutacijaFaza 3
Od 60 do 85 godina · Oba spola · Ažurirano 20. kol 2026. · NCT06976216A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- The Cognitive and Research Center of New Jersey, Springfield
U tijeku regrutacijaFaza 3
Od 55 godina i više · Oba spola · Ažurirano 7. srp 2026. · NCT07602582Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-Flutemetamol
- Nuclear Imaging Institute, Englewood
U tijeku regrutacijaFaza 2Zdravi dobrovoljci dobrodošli
Od 18 do 120 godina · Oba spola · Ažurirano 13. tra 2026. · NCT07012993Open-label Extension Study in Participants With Early Alzheimer's Disease
- GSK Investigational Site, Toms River
U tijeku regrutacijaFaza 2
Od 50 do 85 godina · Oba spola · Ažurirano 2. velj 2026. · NCT07105709Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.